check quantity

RediJect D-Luciferin Ultra Bioluminescent Substrate

RediJect D-Luciferin Ultra (K+ salt) is a novel bioluminescent in vivo substrate in a ready-to-use pre-formulated injectable format developed by the in vivo imaging leaders to fit your laboratory workflow.

Part Number
List Price
Your Price
373.00 USD
Buy Now

Please enter valid quantity

Please log in to add favorites.



Rediject D-Luciferin Ultra is pre-formulated with a fluorescent marker to validate your substrate injection. With PerkinElmer’s Rediject D-Luciferin Ultra you can ensure reproducible results by minimizing variability due to formulation and substrate injection, minimizing freeze/thaw and controlling batch to batch variation.

Rediject D-Luciferin Ultra is pre-formulated with a rapidly clearing fluorescent dye to validate the integrity of your substrate injection, so with a quick fluorescent image on your IVIS system you know immediately if an injection failed and you can normalize your bioluminescence results. With Rediject D-Luciferin Ultra bioluminescent substrate, you can have extra confidence in your data quality.

  • Pre-formulated, batch controlled D-Luciferin for in vivo use 
  • Instantly validate your injection quality and minimize data variability 
  • Save substantial time and effort by minimizing pre-imaging preparation steps 
  • Dispensed to image 5 animals per vial* (10 vials/kit) 
  • In vivo imaging quality, validated on IVIS imaging systems

For laboratory use only. This product is intended for animal research only and not for use in humans.


Luciferase Classification Firefly
Product Brand Name RediJect
Quantity in a Package Amount 1.0 Units
Shipping Condition Blue Ice
Type Luciferin
Unit Size 10 vials
Resources, Events & More
  • All


In Vivo Imaging Solutions eBook

Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and therapeutic efficacies for a broad range of indications. Our reagents, instruments, and applications support have helped hundreds of research projects over the years. And our hard-earned expertise makes us a trusted provider of pre-clinical imaging solutions— with more than 9,000 peer reviewed articles as proof.



XenoLight RediJect D-Luciferin Ultra

XenoLight RediJect D-Luciferin Ultra in ready-to-use injectable format


White Paper

The Role of In Vivo Imaging in Drug Discovery and Development

The primary goal of preclinical imaging is to improve the odds of clinical success and reduce drug discovery and development time and costs. Advances in non-invasive in vivo imaging techniques have raised the use of animal models in drug discovery and development to a new level by enabling quick and efficient drug screening and evaluation. Read this White Paper to learn how preclinical in vivo imaging helps to ensure that smart choices are made by providing Go/No-Go decisions and de-risking drug candidates early on, significantly reducing time to the clinic and lowering costs all while maximizing biological understanding.

PDF 748 KB